XSHG
600226
, Last price
CNY
Name
Zhejiang Hugeleaf Co Ltd
Chart & performance
P/E
—
P/S
—
EPS
0.06
Vol. 1Y
—
Shs. 5Y
-0.92%
Rev. 5Y
27.19%
Div Yld LY
—
Div Yld TTM
—
Revenues
1.85b
+38.60%
Net income
201m
+6.05%
CFO
-148m
L+372.97%
Dividend
Jul 11, 20190.022 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Zhejiang Huge Leaf Co., Ltd. is primarily involved in the production and distribution of biological pesticides, veterinary medications, and animal feed additives. Beyond these core activities, the company also operates in diversified sectors, including combined heat and power generation, the development of online games, and third-party agency distribution services. The firm adopted its current name, Zhejiang Huge Leaf Co., Ltd., in May 2017, transitioning from its former identity as Zhejiang Shenghua Biok Biology Co., Ltd. Its main operational base is located in Shanghai, China.
Key people
Peijin Shen
Chairman of the Board · since 2016
Finance Director · since 2017
Tianxiong Weng
Deputy General Manager · since 2016
Secretary of the Board · since 2013
Weiqun Chen
Deputy General Manager, Director · since 2014
Wenqiu Sun
Vice Chairman of the Board, General Manager · since 2017
Xuanzhen Huang
Independent Director · since 2014
Independent Director
Nianci Zhang
Independent Director
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||